Review
Published on 02 Nov 2016
Tryptophan-Degrading Enzymes in Tumoral Immune Resistance
in Immunological Tolerance and Regulation
Frontiers in Immunology
doi 10.3389/fimmu.2015.00034
- 20,261 views
- 222 citations
78 articles related to "Immune Resistance"
Articles
Review
Published on 28 Apr 2022
Overcoming Immune Resistance With Radiation Therapy in Prostate Cancer
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2022.859785
- 8,242 views
- 18 citations
Editorial
Published on 25 Aug 2023
Editorial: Adaptive immune resistance in cancer therapy
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1277902
- 2,826 views
- 1 citation
Original Research
Published on 27 Apr 2022
TRAF3 Positively Regulates Host Innate Immune Resistance to Influenza A Virus Infection
in Clinical and Diagnostic Microbiology and Immunology
Frontiers in Cellular and Infection Microbiology
doi 10.3389/fcimb.2022.839625
- 4,908 views
- 11 citations
Review
Published on 27 May 2021
Aspects of the Tumor Microenvironment Involved in Immune Resistance and Drug Resistance
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2021.656364
- 51,630 views
- 413 citations
Review
Published on 24 Mar 2023
Nanoparticles overcome adaptive immune resistance and enhance immunotherapy via targeting tumor microenvironment in lung cancer
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1130937
- 7,710 views
- 28 citations
Original Research
Published on 31 Mar 2025
Multidimensional transcriptomics based to illuminate the mechanisms of taurine metabolism in immune resistance of pancreatic cancer
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1567805
- 4,713 views
- 1 citation
Review
Published on 16 Jun 2023
Heterogeneity in functional genetic screens: friend or foe?
in Molecular Innate Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2023.1162706
- 3,290 views
- 1 citation
Original Research
Published on 09 Dec 2025
The aryl hydrocarbon receptor is associated with monocytic AML and innate immune resistance reversible with an AHR inhibitor
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1554166
- 2,148 views
Review
Published on 02 Sep 2022
Targeting immunometabolism mediated by the IDO1 Pathway: A new mechanism of immune resistance in endometrial cancer
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2022.953115
- 7,454 views
- 25 citations
Original Research
Published on 09 Dec 2021
Deficiency of GPI Glycan Modification by Ethanolamine Phosphate Results in Increased Adhesion and Immune Resistance of Aspergillus fumigatus
in Fungal Pathogenesis
Frontiers in Cellular and Infection Microbiology
doi 10.3389/fcimb.2021.780959
- 4,418 views
- 7 citations
Review
Published on 14 Dec 2012
Immune response from a resource allocation perspective
in Livestock Genomics
Frontiers in Genetics
doi 10.3389/fgene.2012.00267
- 24,204 views
- 287 citations
Original Research
Published on 23 Sep 2022
Investigation of the efficacy and safety of cryoablation and intra-arterial PD-1 inhibitor in patients with advanced disease not responding to checkpoint inhibitors: An exploratory study
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2022.990224
- 3,341 views
- 3 citations
Mini Review
Published on 05 Feb 2026
Overcoming immune resistance in ovarian cancer: checkpoint inhibitors, tumor microenvironment, and translational advances
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2026.1762619
- 691 views
Case Report
Published on 30 Jun 2025
Overcoming immune resistance in advanced esophageal squamous cell carcinoma with recombinant human adenovirus type 5 by impacting the immune microenvironment: a case report
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1610058
- 3,245 views
Original Research
Published on 15 Mar 2021
Wnt Inhibition Sensitizes PD-L1 Blockade Therapy by Overcoming Bone Marrow-Derived Myofibroblasts-Mediated Immune Resistance in Tumors
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2021.619209
- 9,195 views
- 30 citations